Skip to main content
TIBET AIM PHARM. INC. logo

TIBET AIM PHARM. INC. — Investor Relations & Filings

Ticker · 002826 ISIN · CNE100002C39 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,084 across all filing types
Latest filing 2026-04-23 Declaration of Voting R…
Country CN China
Listing Shenzhen Stock Exchange 002826

About TIBET AIM PHARM. INC.

https://www.emyy.cn

Tibet Aim Pharm. Inc. is a pharmaceutical enterprise focused on the research, development, production, and distribution of medicinal products. The company integrates traditional Tibetan medicine with modern pharmaceutical manufacturing processes to develop a diverse portfolio of treatments. Its core product range typically includes cardiovascular medications, digestive system therapies, and specialized herbal formulations derived from high-altitude botanical sources. Tibet Aim Pharm. Inc. emphasizes the modernization of traditional formulas through rigorous clinical testing and standardized production techniques. The company serves healthcare providers and patients by providing therapeutic solutions that bridge ancient medical knowledge with contemporary scientific standards.

Recent filings

Filing Released Lang Actions
2026年第二次临时股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 92% confidence The document is an official announcement by the company of the resolutions and voting results of its 2026 second extraordinary general shareholders meeting. It details meeting attendance, voting procedures and the vote counts for multiple proposals. This matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-04-23 Chinese
关于2026年限制性股票激励计划首次授予登记完成的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from a company regarding the completion of the first grant registration of a 2026 restricted stock incentive plan. It details the stock grant date, number of shares, prices, recipients, approval procedures, performance conditions, and related accounting treatments. The content focuses on the stock incentive plan implementation and related share repurchase details. It is not a full financial report, earnings release, or management discussion, but rather a formal announcement about a capital/financing event related to stock incentives and share repurchases. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length and detail confirm it is not a brief announcement or a regulatory filing fallback. Confidence is high due to the specificity and detailed nature of the stock incentive and share repurchase information.
2026-04-09 Chinese
董事、高级管理人员离职管理制度
Governance Information Classification · 95% confidence The document is a detailed internal policy titled '董事、高级管理人员离职管理制度' (Management System for the Resignation of Directors and Senior Management) of a company. It outlines procedures, principles, responsibilities, and legal compliance related to the resignation and departure of directors and senior management personnel. There are no financial statements, earnings data, or investor presentations. It is not an announcement of a report, nor a certification or legal proceeding update. It is a governance-related document focusing on internal rules and management practices concerning board and senior management changes. Therefore, it fits best under Governance Information (CGR). The document length is 4003 characters, which is substantive and not a brief announcement.
2026-04-07 Chinese
融资与对外担保管理制度
Governance Information Classification · 95% confidence The document is titled '融资与对外担保管理制度' which translates to 'Financing and External Guarantee Management System' and is issued by 西藏易明西雅医药科技股份有限公司. It is a detailed internal policy document outlining the company's procedures, approval processes, risk management, and disclosure obligations related to financing and external guarantees. The content includes governance rules, approval thresholds, risk controls, and responsibilities of company personnel. There is no indication that this is a financial report, earnings release, or regulatory filing. It is not an announcement or a report publication notice but a governance or management internal document. Given the detailed nature of the management rules and procedures, this fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices. The document length (5432 characters) and content support this classification with high confidence.
2026-04-07 Chinese
中小投资者单独计票管理办法
Governance Information Classification · 95% confidence The document is titled '中小投资者单独计票管理办法' which translates to 'Management Measures for Separate Voting by Minority Investors.' It is a procedural and regulatory document detailing the rules and procedures for separate vote counting for minority shareholders in company meetings. It includes references to legal and regulatory frameworks, voting procedures, disclosure requirements, and governance practices related to shareholder meetings. There is no financial data, earnings information, or report publication announcement. The content focuses on governance and shareholder voting rules, which aligns with Governance Information filings. The document length is 2477 characters, which is relatively short and consistent with a governance policy document rather than a full report or announcement. Therefore, the appropriate classification is Governance Information (CGR).
2026-04-07 Chinese
独立董事专门会议制度
Governance Information Classification · 95% confidence The document is titled '独立董事专门会议制度' which translates to 'Independent Directors Special Meeting System' and details the governance procedures and rules for independent directors' meetings within the company. It references company bylaws, regulatory frameworks, and internal governance practices. There is no financial data, no mention of financial results, no voting results, no announcements of report publications, or any other regulatory filings. The content is focused on governance structure and internal rules for board meetings, specifically for independent directors. Therefore, this document fits best under Governance Information (CGR). The document length is 2451 characters, which is relatively short but contains substantive governance content, not just an announcement or notice.
2026-04-07 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.